Harrow Health (HROWM) Stock Analysis

What Harrow Health does

Harrow Health, Inc. focuses on the creation, production, and marketing of cutting-edge pharmaceutical solutions. Its business activities are primarily organized into two distinct divisions: Pharmaceutical Compounding and Pharmaceutical Drug Development. Specifically, the Pharmaceutical Compounding segment oversees the operations of the ImprimisRx enterprise. The company was established in January 2006 by Mark L. Baum and Robert J. Kammer, and its main corporate office is located in Nashville, Tennessee.

Key metrics

ETFs linked to HROWM

Broad-market and Healthcare sector ETFs an investor holding Harrow Health is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HROWM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Harrow Health?

Harrow Health trades under the ticker HROWM on NASDAQ.

Which exchange is HROWM listed on?

HROWM is listed on NASDAQ.

What sector does Harrow Health operate in?

Harrow Health is classified in the Healthcare sector (Medical - Pharmaceuticals industry).

How can PortView help analyze HROWM in a portfolio?

PortView shows HROWM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.